Company Filing History:
Years Active: 2017
Title: Florence Dal Degan: Innovator in Immunology
Introduction
Florence Dal Degan is a prominent inventor based in Cheney, France. She has made significant contributions to the field of immunology through her innovative research and development of novel polypeptides.
Latest Patents
Florence holds a patent for her invention titled "PAN-DR binding polypeptides and uses thereof." This patent provides novel artificial oligopeptides capable of binding HLA Class II molecules encoded by several alleles. The oligopeptides include the sequence AXFVAAXTLXAXA (SEQ ID NO:1), wherein X is H; X is selected from the group consisting of F, N, Y, and W; X is H and X is selected from the group consisting of A, D, and E. The invention also relates to large peptides comprising the oligopeptides, polynucleotides encoding the oligopeptides and larger peptides, as well as to compositions comprising the oligopeptides, peptides, or polynucleotides. Additionally, methods for inducing immune responses are disclosed in her patent.
Career Highlights
Florence is currently associated with Epimmune Inc., where she continues her groundbreaking work in immunology. Her research has the potential to advance therapeutic strategies for various immune-related conditions.
Collaborations
Florence has collaborated with notable colleagues, including Mark Joseph Newman and Jeffery L Alexander, contributing to a dynamic research environment that fosters innovation.
Conclusion
Florence Dal Degan is a trailblazer in the field of immunology, with her patent and ongoing work promising to make significant impacts in medical science. Her contributions exemplify the importance of innovation in addressing complex health challenges.